Agammaglobulinemia-early-onset hypertrophic cardiomyopathy-neutropenia syndrome (FNIP1 deficiency): A Patient Guide

Receiving a diagnosis of Agammaglobulinemia-early-onset hypertrophic cardiomyopathy-neutropenia syndrome, often referred to as FNIP1 deficiency, means entering a very small community of families and researchers. This is an exceptionally rare inborn error of immunity, a recently discovered genetic condition where the body’s natural defense system and the heart muscle develop differently. Because only a very small number of children worldwide have been identified with this specific diagnosis, you and your medical team are working with the most current frontier of medical science ^[1][2].

At its core, this condition is caused by a missing protein called FNIP1, which is proposed to normally act as a “fuel gauge” and energy regulator for your child’s cells. When this protein is absent, two main systems are affected: the immune system and the heart. The immune system lacks antibodies, a condition called agammaglobulinemia, and often has severely reduced or absent B cells, the specialized white blood cells that produce those antibodies. This leaves the body vulnerable to repeated infections of the lungs, sinuses, and digestive tract ^[1][3].

At the same time, the energy-sensing problem in the cells can cause the heart muscle to become abnormally thick, a condition known as hypertrophic cardiomyopathy. Researchers hypothesize this thickening happens because the heart cells receive the wrong signals about how to grow and store energy. In some children, this can also affect the heart’s electrical system, potentially leading to an increased risk of fast or irregular heartbeats. Some patients also experience neutropenia, where another type of infection-fighting cell, the neutrophil, may be low either some of the time or constantly ^[4][5].

Living with this diagnosis means navigating a path of careful, ongoing monitoring and protective care. Your child will likely be supported by a small, dedicated team of specialists, including immunologists and cardiologists, who focus on replacing missing antibodies and supporting the heart’s function. While the diagnosis is complex and the science is still evolving, the primary goal of care is to protect your child from infections and manage heart health so they can thrive. You are your child’s most important advocate, and this guide is designed to empower you with the information you need to partner with your medical team ^[1][2].

Note: The evidence for managing this condition comes mainly from a very small number of reported patients. This guide is educational and does not replace your child’s individualized emergency or treatment plan.